Biofrontera Inc.
BFRI
Kedudukan dalam Saham
#31614
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization... Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Harga Saham
$0.8066
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$11.98M
Perubahan (1 hari)
0.11%
Perubahan (1 tahun)
-72.66%
Negara
US
Perdagangan Biofrontera Inc. (BFRI)
Kategori
Healthcare
Sejarah harga saham bagi Biofrontera Inc. (BFRI)
Harga penutupan tertinggi: $2.93 pada 2024-06-01
Harga penutupan terendah: $328.16 pada 2006-10-01
Harga penutupan terendah: $328.16 pada 2006-10-01
Sejarah harga saham Biofrontera Inc. dari 2006 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2024 | -73.04% |
| 2023 | -68.52% |
| 2022 | -5.85% |
| 2021 | -48.56% |
| 2020 | -30.24% |
| 2019 | -15.14% |
| 2018 | 34.15% |
| 2017 | 41.58% |
| 2016 | 70.60% |
| 2015 | -31.22% |
| 2014 | -36.74% |
| 2013 | -4.76% |
| 2012 | 28.04% |
| 2011 | 56.02% |
| 2010 | -25.62% |
| 2009 | 48.88% |
| 2008 | -87.41% |
| 2007 | -3.58% |
| 2006 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $62.21 | 65.98% |
US
|
|
| $50.49 | 50.82% |
SE
|
|
| $180.41 | 37.52% |
FR
|
|
| $62.81 | 5.96% |
IT
|
|
| $116.87 | 55.01% |
US
|
